These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 25596473)
1. Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis. Gharibi T; Ahmadi M; Seyfizadeh N; Jadidi-Niaragh F; Yousefi M Cell Immunol; 2015 Feb; 293(2):113-21. PubMed ID: 25596473 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors. Kassis I; Petrou P; Halimi M; Karussis D Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102 [TBL] [Abstract][Full Text] [Related]
4. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962 [TBL] [Abstract][Full Text] [Related]
5. Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis. Bravo B; Gallego MI; Flores AI; Bornstein R; Puente-Bedia A; Hernández J; de la Torre P; García-Zaragoza E; Perez-Tavarez R; Grande J; Ballester A; Ballester S Stem Cell Res Ther; 2016 Mar; 7():43. PubMed ID: 26987803 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis. Xiao J; Yang R; Biswas S; Qin X; Zhang M; Deng W Int J Mol Sci; 2015 Apr; 16(5):9283-302. PubMed ID: 25918935 [TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of bone marrow-derived mesenchymal stem cell transplantation in a non-immune model of demyelination. El-Akabawy G; Rashed LA Ann Anat; 2015 Mar; 198():11-20. PubMed ID: 25660362 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells as treatment for MS - progress to date. Uccelli A; Laroni A; Freedman MS Mult Scler; 2013 Apr; 19(5):515-9. PubMed ID: 23124791 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [TBL] [Abstract][Full Text] [Related]
11. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288 [TBL] [Abstract][Full Text] [Related]
12. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Yousefi F; Ebtekar M; Soudi S; Soleimani M; Hashemi SM Immunol Lett; 2016 Apr; 172():94-105. PubMed ID: 26930038 [TBL] [Abstract][Full Text] [Related]
13. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS). Al Jumah MA; Abumaree MH Int J Mol Sci; 2012; 13(7):9298-9331. PubMed ID: 22942767 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells as a treatment for multiple sclerosis: a focus on experimental animal studies. Lotfy A; Ali NS; Abdelgawad M; Salama M Rev Neurosci; 2020 Jan; 31(2):161-179. PubMed ID: 31605598 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis. Cobo M; Anderson P; Benabdellah K; Toscano MG; Muñoz P; García-Pérez A; Gutierrez I; Delgado M; Martin F Cell Transplant; 2013; 22(5):839-54. PubMed ID: 23031550 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis. Liao W; Pham V; Liu L; Riazifar M; Pone EJ; Zhang SX; Ma F; Lu M; Walsh CM; Zhao W Biomaterials; 2016 Jan; 77():87-97. PubMed ID: 26584349 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice. Abramowski P; Krasemann S; Ernst T; Lange C; Ittrich H; Schweizer M; Zander AR; Martin R; Fehse B Stem Cells Dev; 2016 Aug; 25(15):1134-48. PubMed ID: 27250994 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis. Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Fallah A; Tahoori MT; Amari A; Forouzandeh M; Soleimani M Clin Immunol; 2016 Aug; 169():98-106. PubMed ID: 27373971 [TBL] [Abstract][Full Text] [Related]
20. Human umbilical cord stem cells ameliorate experimental autoimmune encephalomyelitis by regulating immunoinflammation and remyelination. Liu R; Zhang Z; Lu Z; Borlongan C; Pan J; Chen J; Qian L; Liu Z; Zhu L; Zhang J; Xu Y Stem Cells Dev; 2013 Apr; 22(7):1053-62. PubMed ID: 23140594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]